PASSIVE IMMUNOTHERAPY OF ESTABLISHED TUMORS WITH SYNGENEIC ANTITUMOR SERUM IN COMBINATION WITH IMMUNOPOTENTIATORS
-
- SHINODA Hirotaka
- Faculty of Pharmaceutical Sciences, University of Tokyo
-
- YAMAZAKI Masatoshi
- Faculty of Pharmaceutical Sciences, University of Tokyo
-
- MIZUNO Den'ichi
- Faculty of Pharmaceutical Sciences, University of Tokyo
Bibliographic Information
- Other Title
-
- Passive Immunotherapy of Established Tumor with Syngeneic Antitumor Serum in Combination with Immunopotentiators
- Passive Immunotherapy of Established Tu
Search this article
Abstract
The possibility of passive therapy of 6∼8-day established tumors with syngeneic antitumor antiserum was tested using (1) combination of the antiserum and immunopotentiators, (2) combination of the antiserum and inflammatory agents, and (3) repeated injections of antiserum. Therapeutic effect on an ascites tumor was seen using antiserum in combination with BCG or lipopolysaccharide, or less clearly with carrageenan. Combinations of antiserum and PS-K, histamine, or croton oil did not have a synergistic therapeutic effect, but repeated injection of a small amount of antiserum did have a therapeutic effect on established peritoneal and subcutaneous tumors.
Journal
-
- GANN Japanese Journal of Cancer Research
-
GANN Japanese Journal of Cancer Research 68 (5), 567-571, 1977
The Japanese Cancer Association
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205529228416
-
- NII Article ID
- 130006409720
- 40000528974
-
- NII Book ID
- AN00045888
-
- NDL BIB ID
- 1847456
-
- ISSN
- 0016450X
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- CiNii Articles
-
- Abstract License Flag
- Disallowed